Cerebrolysin (CMAX) Therapy
A peptide-based therapy explored for brain repair and cognitive function, in specialized supervised settings.
Cerebrolysin is studied for its potential to support neuronal repair and cognition. It’s used in specialized, medically supervised settings and is not FDA-approved in the U.S.
What is Cerebrolysin?
A peptide preparation derived from brain proteins, studied internationally for neurological and cognitive support.
How it works
It’s thought to have neurotrophic effects — supporting the survival and repair of neurons — though mechanisms and evidence are still being defined.
What it’s explored for
Brain fog; traumatic brain injury recovery; age-related cognitive decline.
Why patients are interested
Interest centers on memory, clarity, and neuronal repair support.
What to expect
Patients describe subtle but meaningful cognitive improvements; effects vary by individual.
Safety & side effects
Used under specialized supervision; effects and suitability are reviewed individually given limited U.S. data.
Who is (and isn’t) a candidate
Determined by consultation; appropriate only in carefully supervised settings.
Regulatory & sourcing status
Cerebrolysin is not FDA-approved in the United States and is considered investigational here, used only in specialized medical settings.
Last reviewed: 06/07/2026


